As illustrated in the upper part of Fig 4A, we successfully identified CEBPA, NRAS, KIT, KRAS and RUNX1 as specific genes for adults with AML compared to those with GBM, and these genes are typical members of the acute myeloid leukemia pathway. This evidence concerns the gene RUNX1 and glioblastoma.